SCHEMBL5607955

SCHEMBL5607955

CCCCNC(=O)Nc1nc(C)c(C(=O)Nc2c(C)cc(Br)cc2C)s1.CCCCNC(=O)Nc1nc(C)c(C(=O)Nc2c(C)cccc2Cl)s1

nearest known ligand 0.86

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
LCK P06239 16/20 0.86
CHRNA7 P36544 2/20 0.52
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
HTT P42858 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL775446 0.93 LCK (1.00) LCKCHRNA7ALDH1A1LMNAHTT
SCHEMBL772665 0.90 LCK (0.84) LCKALDH1A1
SCHEMBL773159 0.88 LCK (0.90) LCKCHRNA7ALDH1A1LMNAHTT
SCHEMBL774052 0.88 LCK (0.86) LCKCHRNA7
SCHEMBL773918 0.82 LCK (1.00) LCKALDH1A1
SCHEMBL5607857 0.82 LCK (0.78) LCKCHRNA7
SCHEMBL774897 0.80 LCK (0.86) LCK
SCHEMBL773377 0.80 LCK (0.76) LCKALDH1A1
SCHEMBL1539966 0.80 LCK (0.67) LCKLMNA
SCHEMBL772952 0.80 LCK (0.76) LCKALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758564-A2 SYNERGISTIC METHODS AND COMPOSITIONS FOR TREATING CANCER Brystol-Myers Squibb Company (US) 2007-03-07 EP claimed
WO-2005094376-A2 SYNERGISTIC METHODS AND COMPOSITIONS FOR TREATING CANCER BRISTOL-MYERS SQUIBB COMPANY (US) 2005-10-13 WO claimed